Establishment Labs Holdings Inc 8-K, filed Jun 1, 2022
Establishment Labs Holdings Inc. (ESTA)
8-K
2022-06-01
For: 2022-05-26
View Original
Added on
April 08, 2026
About this 8-K
Establishment Labs Holdings Inc filed this 8-K on June 1, 2022, reporting on events of May 26, 2022.
Items reported
- Item 8.01: Other events
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
| Date of Report (date of earliest event reported) | ||
(Exact name of registrant as specified in its charter)
| Not applicable | ||||||||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (Commission File No.) | (I.R.S. Employer Identification Number) | ||||||||||||||||||
| (Address of principal executive offices) (Zip Code) | ||||||||||||||||||||
| +506 2434 2400 | ||||||||||||||||||||
| (Registrant’s telephone number, including area code) | ||||||||||||||||||||
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||
The | ||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2) of this chapter.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On May 26, 2022, Establishment Labs Holdings Inc. (the “Company”), through its wholly owned subsidiary, Establishment Labs, S.A., exercised its option to purchase the title of the land and cold shell building located at B-23, Coyol Free Zone, Alajuela, Costa Rica. As previously disclosed, the Company entered into a contract with the Zona Franca Coyol, S.A., in 2021 to begin construction of a new manufacturing facility in Costa Rica with an option to purchase the title to the land and cold shell building for approximately $12.6 million. On May 26, 2022, the Company made its first payment of approximately $9.5 million in connection with the exercise of this option. The remaining approximately $3.1 million payment is expected to be made before the end of fiscal year 2022.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
ESTABLISHMENT LABS HOLDINGS INC. | ||||||||||||||
Dated: | June 1, 2022 | By: | /s/ Rajbir S. Denhoy | |||||||||||
Name: | Rajbir S. Denhoy | |||||||||||||
Title: | Chief Financial Officer | |||||||||||||